{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T08:57:18Z","timestamp":1785574638979,"version":"3.56.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Prostate cancer (PCa) is a common malignancy of the urinary tract. Hormone therapy is the primary clinical option for the treatment of PCa; however, some PCa patients succumb to the disease due to malignant progression. This study aimed to identify new therapeutic agents for PCa and their potential molecular mechanisms of action, which will provide new insights into the treatment and prognosis of PCa.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Following the overexpression or knockdown of Kr\u00fcppel-like factor 7 (\n                      <jats:italic toggle=\"yes\">KLF7<\/jats:italic>\n                      ) in PC-3 cells, we performed RNA sequencing (RNA-seq) and bioinformatics analyses to identify oncogenic factors regulated by\n                      <jats:italic toggle=\"yes\">KLF7<\/jats:italic>\n                      . A dual-luciferase reporter assay, Chromatin immunoprecipitation (ChIP) and quantitative real-time polymerase chain reaction (qRT\u2013PCR) were used to evaluate the transcriptional regulation of L1 cell adhesion molecule (\n                      <jats:italic toggle=\"yes\">L1CAM<\/jats:italic>\n                      ) by\n                      <jats:italic toggle=\"yes\">KLF7<\/jats:italic>\n                      Pca cells. The impact of NF-\u03baB p65 phosphorylation (NF-\u03baB p-p65) on KLF7 and L1CAM expression was investigated by qRT\u2013PCR, Western blotting, and gallic acid (GA) treatment was applied to examine its effects on the proliferation, invasion, and migration of PC-3 cells by cell counting kit\u20108 (CCK8) assay, cell invasion and migration assays, cell scratch assay and colony formation assay. The binding affinity of GA for the NF-\u03baB p65 protein was subsequently assessed via surface plasmon resonance (SPR) analysis.\n                      <jats:italic toggle=\"yes\">In vivo<\/jats:italic>\n                      experiments were conducted using C57BL\/6 mice models to evaluate the therapeutic potential of GA.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Our results demonstrated that high expression of KLF7 promoted the proliferation, invasion, and migration of PCa cells through the transcriptional activation of\n                      <jats:italic toggle=\"yes\">L1CAM<\/jats:italic>\n                      . Additionally, phosphorylation of NF-\u03baB p65 enhanced the malignant phenotype of PCa cells via upregulation of KLF7\/L1CAM axis. GA attenuated the malignant phenotype of PCa cells by inhibiting the transcriptional activation of KLF7 via p-p65. Furthermore, in mice, GA gavage attenuated the malignant phenotype of PCa cells through the inhibition of p65.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>\n                      These findings indicated that GA could decrease L1CAM expression by inhibiting the transcriptional activation of\n                      <jats:italic toggle=\"yes\">KLF7<\/jats:italic>\n                      via p-p65, in turn attenuating the malignant phenotype and tumorigenic capacity of PCa cells\n                      <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cm9.0000000000004202","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T02:00:49Z","timestamp":1784167249000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Gallic acid attenuates the malignant phenotype of prostate cancer cells by antagonizing NF-\u03baB\/KLF7\/L1CAM expression"],"prefix":"10.1097","author":[{"given":"Jie","family":"Liu","sequence":"first","affiliation":[{"name":"Laboratory of Xinjiang Endemic and Ethic Diseases, Shihezi University, Shihezi, Xinjiang 832000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibo","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Basic Medicine, Shihezi University School of Medicine, Bei-Er-Lu, Shihezi, Xinjiang 832000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Tong","sequence":"additional","affiliation":[{"name":"Clinical Medical College, Shihezi University, Shihezi, Xinjiang 832000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenggang","family":"Yuan","sequence":"additional","affiliation":[{"name":"Xinjiang College of Science & Technology, Korla, Xinjiang 841000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanting","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Basic Medicine, Shihezi University School of Medicine, Bei-Er-Lu, Shihezi, Xinjiang 832000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maodi","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Basic Medicine, Shihezi University School of Medicine, Bei-Er-Lu, Shihezi, Xinjiang 832000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Basic Medicine, Shihezi University School of Medicine, Bei-Er-Lu, Shihezi, Xinjiang 832000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyue","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Basic Medicine, Shihezi University School of Medicine, Bei-Er-Lu, Shihezi, Xinjiang 832000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyang","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Basic Medicine, Shihezi University School of Medicine, Bei-Er-Lu, Shihezi, Xinjiang 832000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Xie","sequence":"additional","affiliation":[{"name":"Tarim University School of Medicine, Alar, Xinjiang 843300, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuizhe","family":"Wang","sequence":"additional","affiliation":[{"name":"Medical Genetics Teaching and Research Section, Medical College, Shihezi University, Bei-Er-Lu, Shihezi, Xinjiang 832000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingzhou","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Basic Medicine, Shihezi University School of Medicine, Bei-Er-Lu, Shihezi, Xinjiang 832000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Laboratory of Xinjiang Endemic and Ethic Diseases, Shihezi University, Shihezi, Xinjiang 832000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"R1-20260801","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5061867","article-title":"Effect of combining traditional Chinese medicine with hormonal therapy on quality of life and tumor markers of prostate cancer patients","volume":"2021","author":"Gai","year":"2021","journal-title":"Evid Based Complement Alternat Med"},{"key":"R2-20260801","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21681805.2020.1851762","article-title":"Time spent in hormone-sensitive and castration-resistant disease states in men with advanced prostate cancer, and its health economic impact: Registry-based study in Sweden","volume":"55","author":"Svensson","year":"2021","journal-title":"Scand J Urol"},{"key":"R3-20260801","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.2147\/CMAR.S236301","article-title":"Free fatty acids promote the development of prostate cancer by upregulating peroxisome proliferator-activated receptor gamma","volume":"12","author":"Ha","year":"2020","journal-title":"Cancer Manag Res"},{"key":"R4-20260801","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1186\/s12885-023-10841-2","article-title":"Caprylic acid (FFA C8:0) promotes the progression of prostate cancer by up-regulating G protein-coupled receptor 84\/kruppel-like factor 7","volume":"23","author":"Li","year":"2023","journal-title":"BMC Cancer"},{"key":"R5-20260801","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107538","article-title":"NF-kappaB signaling promotes castration-resistant prostate cancer initiation and progression","volume":"211","author":"Thomas-Jardin","year":"2020","journal-title":"Pharmacol Ther"},{"key":"R6-20260801","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1093\/nar\/gkz108","article-title":"LncRNA PCAT1 activates AKT and NF-kappaB signaling in castration-resistant prostate cancer by regulating the PHLPP\/FKBP51\/IKKalpha complex","volume":"47","author":"Shang","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"R7-20260801","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/pros.24045","article-title":"Determining the prognostic significance of IKKalpha in prostate cancer","volume":"80","author":"Montes","year":"2020","journal-title":"Prostate"},{"key":"R8-20260801","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41387-022-00202-6","article-title":"Obesity-induced elevated palmitic acid promotes inflammation and glucose metabolism disorders through GPRs\/NF-kappaB\/KLF7 pathway","volume":"12","author":"Qiu","year":"2022","journal-title":"Nutr Diabetes"},{"key":"R9-20260801","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2021.112576","article-title":"Gallic acid for cancer therapy: Molecular mechanisms and boosting efficacy by nanoscopical delivery","volume":"157","author":"Ashrafizadeh","year":"2021","journal-title":"Food Chem Toxicol"},{"key":"R10-20260801","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2024.114068","article-title":"Dietary gallic acid as an antioxidant: A review of its food industry applications, health benefits, bioavailability, nano-delivery systems, and drug interactions","volume":"180","author":"Xiang","year":"2024","journal-title":"Food Res Int"},{"key":"R11-20260801","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/19390211.2017.1335822","article-title":"Ameliorative effect of gallic acid in doxorubicin-induced hepatotoxicity in Wistar rats through antioxidant defense system","volume":"15","author":"Omobowale","year":"2018","journal-title":"J Diet Suppl"},{"key":"R12-20260801","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.reprotox.2022.12.008","article-title":"Protective effect of gallic acid on doxorubicin-induced ovarian toxicity in mouse","volume":"115","author":"Silva","year":"2023","journal-title":"Reprod Toxicol"},{"key":"R13-20260801","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/13813455.2019.1630652","article-title":"Protective effects of gallic acid on doxorubicin-induced cardiotoxicity; an experimantal study","volume":"127","author":"Ekinci Akdemir","year":"2021","journal-title":"Arch Physiol Biochem"},{"key":"R14-20260801","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1515\/jbcpp-2016-0194","article-title":"Ameliorative effect of gallic acid on doxorubicin-induced cardiac dysfunction in rats","volume":"29","author":"Omobowale","year":"2018","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"R15-20260801","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1039\/C8FO01439F","article-title":"Screening for active constituents in Turkish galls against ulcerative colitis by mass spectrometry guided preparative chromatography strategy: In silico, in vitro and in vivo study","volume":"9","author":"Zang","year":"2018","journal-title":"Food Funct"},{"key":"R16-20260801","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.21873\/anticanres.16915","article-title":"Antiproliferative and antimigratory activity of poly-gallic acid in cancer cell lines","volume":"44","author":"Hernandez-Valencia","year":"2024","journal-title":"Anticancer Res"},{"key":"R17-20260801","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1097\/CM9.0000000000003538","article-title":"LGR5 interacts with HSP90AB1 to mediate enzalutamide resistance by activating the WNT\/\u03b2-catenin\/AR axis in prostate cancer","volume":"138","author":"Gao","year":"2025","journal-title":"Chin Med J"},{"key":"R18-20260801","article-title":"Clostridium difficile infection is associated with decreased prostate cancer risk: A retrospective cohort study","volume":"15","author":"Frankel","year":"2023","journal-title":"Cureus"},{"key":"R19-20260801","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1006101","article-title":"Exploring anti-androgen therapies in hormone dependent prostate cancer and new therapeutic routes for castration resistant prostate cancer","volume":"13","author":"Harris","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R20-20260801","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1080\/17425255.2021.1970745","article-title":"Risk of cardiovascular toxicities and hypertension in nonmetastatic castration-resistant prostate cancer patients treated with novel hormonal agents: A systematic review and meta-analysis","volume":"17","author":"Rizzo","year":"2021","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R21-20260801","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1038\/s41388-019-0736-3","article-title":"Prostate cancer promotes a vicious cycle of bone metastasis progression through inducing osteocytes to secrete GDF15 that stimulates prostate cancer growth and invasion","volume":"38","author":"Wang","year":"2019","journal-title":"Oncogene"},{"key":"R22-20260801","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/cncr.21778","article-title":"Metastatic patterns in adenocarcinoma","volume":"106","author":"Hess","year":"2006","journal-title":"Cancer"},{"key":"R23-20260801","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrc3055","article-title":"Cancer to bone: A fatal attraction","volume":"11","author":"Weilbaecher","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"R24-20260801","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.129618","article-title":"Cytotoxic and epigenetic effects of berberine-loaded chitosan\/pectin nanoparticles on AGS gastric cancer cells: Role of the miR-185-5p\/KLF7 axis, DNMTs, and global DNA methylation","volume":"260","author":"Babaeenezhad","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"R25-20260801","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12885-024-11826-5","article-title":"Palmitic acid-activated GPRs\/KLF7\/CCL2 pathway is involved in the crosstalk between bone marrow adipocytes and prostate cancer","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Cancer"},{"key":"R26-20260801","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s43018-019-0006-x","article-title":"L1CAM defines the regenerative origin of metastasis-initiating cells in colorectal cancer","volume":"1","author":"Ganesh","year":"2020","journal-title":"Nat Cancer"},{"key":"R27-20260801","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122684","article-title":"NF-kappaB signaling in therapy resistance of breast cancer: Mechanisms, approaches, and challenges","volume":"348","author":"Guo","year":"2024","journal-title":"Life Sci"},{"key":"R28-20260801","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/jcmm.14839","article-title":"PNPLA3 I148M mediates the regulatory effect of NF-kB on inflammation in PA-treated HepG2 cells","volume":"24","author":"Yuan","year":"2020","journal-title":"J Cell Mol Med"},{"key":"R29-20260801","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/cells7090122","article-title":"Inflammation and NF-kappaB signaling in prostate cancer: Mechanisms and clinical implications","volume":"7","author":"Staal","year":"2018","journal-title":"Cells"},{"key":"R30-20260801","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7616696","article-title":"Exosomal CXCL14 contributes to M2 macrophage polarization through NF-kappaB signaling in prostate cancer","volume":"2022","author":"Tian","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"R31-20260801","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1038\/s41467-022-34871-9","article-title":"ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression","volume":"13","author":"Li","year":"2022","journal-title":"Nat Commun"},{"key":"R32-20260801","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1055\/a-2339-2633","article-title":"(R)-(-)-Xanthorrhizol inhibits the migration and invasion of triple-negative breast cancer cells by suppressing matrix metalloproteinases via the NF-kB signaling pathway","volume":"90","author":"Al-Amin","year":"2024","journal-title":"Planta Med"},{"key":"R33-20260801","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s11655-021-3345-2","article-title":"Gallic acid: A potential anti-cancer agent","volume":"28","author":"Jiang","year":"2022","journal-title":"Chin J Integr Med"},{"key":"R34-20260801","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.yrtph.2018.11.010","article-title":"Acute and 28-days repeated dose sub-acute toxicity study of gallic acid in albino mice","volume":"101","author":"Variya","year":"2019","journal-title":"Regul Toxicol Pharmacol"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CM9.0000000000004202","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T08:00:14Z","timestamp":1785571214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CM9.0000000000004202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":34,"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000004202","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"2026-04-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}